Back to top
more

Elanco Animal Health (ELAN)

(Real Time Quote from BATS)

$12.71 USD

12.71
1,248,050

+0.30 (2.42%)

Updated Oct 3, 2022 11:14 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.51%
2Buy17.96%
3Hold9.47%
4Sell5.16%
5Strong Sell2.21%
S&P50010.66%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 14% (217 out of 251)

Industry: Medical - Outpatient and Home Healthcare

Trades from $1

Zacks News

Elanco Animal Health Incorporated (ELAN) Tops Q2 Earnings Estimates

Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 38.46% and 0.24%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

AlerisLife (ALR) Reports Q2 Loss, Misses Revenue Estimates

Five Star (ALR) delivered earnings and revenue surprises of -33.33% and 4.48%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Aveanna Healthcare (AVAH) Q2 Earnings Expected to Decline

Aveanna (AVAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DaVita HealthCare (DVA) Tops Q2 Earnings Estimates

DaVita HealthCare (DVA) delivered earnings and revenue surprises of 9% and 0.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Elanco Animal Health Incorporated (ELAN) to Report a Decline in Earnings: What to Look Out for

Elanco Animal Health Incorporated (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Amedisys (AMED) Q2 Earnings Beat Estimates

Amedisys (AMED) delivered earnings and revenue surprises of 19.51% and 4.10%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Elanco Animal Health Incorporated (ELAN) Surpasses Q1 Earnings and Revenue Estimates

Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 2.86% and 0.71%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Is a Surprise Coming for Elanco (ELAN) This Earnings Season?

Elanco (ELAN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

U.S. Physical Therapy (USPH) Q1 Earnings and Revenues Top Estimates

U.S. Physical Therapy (USPH) delivered earnings and revenue surprises of 3.17% and 1.85%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Debasmita Chatterjee headshot

3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1

Improved patient volumes, a diversified healthcare portfolio and various technological advancements are likely to favor first-quarter results of ELAN, DCGO and OMIC.

Why Elanco Animal Health Incorporated (ELAN) Could Beat Earnings Estimates Again

Elanco Animal Health Incorporated (ELAN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Amedisys (AMED) Q1 Earnings Top Estimates

Amedisys (AMED) delivered earnings and revenue surprises of 10.81% and 2.25%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Elanco Animal Health Incorporated (ELAN) Q4 Earnings and Revenues Beat Estimates

Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 23.53% and 1.11%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Elanco Animal Health Incorporated (ELAN) Reports Next Week: Wall Street Expects Earnings Growth

Elanco Animal Health Incorporated (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Top Estimates

Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 11.76% and 4.27%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Elanco Animal Health Incorporated (ELAN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Elanco Animal Health Incorporated (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AVAH vs. ELAN: Which Stock Is the Better Value Option?

AVAH vs. ELAN: Which Stock Is the Better Value Option?

Elanco Animal Health Incorporated (ELAN) Beats Q2 Earnings and Revenue Estimates

Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 7.69% and 3.10%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Should You Buy Elanco (ELAN) Ahead of Earnings?

Elanco (ELAN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Elanco Animal Health Incorporated (ELAN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Elanco Animal Health Incorporated (ELAN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Elanco Animal Health Incorporated (ELAN) Could Beat Earnings Estimates Again

Elanco Animal Health Incorporated (ELAN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

The Zacks Analyst Blog Highlights: National Vision, DaVita, Elanco Animal Health, Henry Schein and Phibro Animal Health

The Zacks Analyst Blog Highlights: National Vision, DaVita, Elanco Animal Health, Henry Schein and Phibro Animal Health

5 Probable MedTech Winners Post-COVID on Discounted PEG

Here are some MedTech stocks with favorable PEG ratio, which are expected to provide gains in 2021.

Top Ranked Momentum Stocks to Buy for June 9th

TITN, NVDA, GIII, and ELAN made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 9, 2021.

Top Ranked Momentum Stocks to Buy for May 21st

ARCB, CNR, ELAN, and OSK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 21, 2021